PPARGC1A and Parkinson disease: In the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model, hyperbaric oxygen therapy can increase PGC-1α expression and improve DA neuron death and motor deficits [56].